MedTrace Logo

Toward a Comprehensive Supportive Care Intervention for Older or Frail Men With mCRPC

NCT04193657 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 91

Last updated 2022-05-18

No results posted yet for this study

Summary

1. Multicentre pilot study (n=90) which aims to study a prevalent population of elderly or frail patients with mCRPC whom are often excluded from clinical trial participation. (Data is sorely needed in this population)
2. The study aims to determine:

1. if symptom monitoring (daily) is feasible using telephone or electronic means of communications in the elderly or frail patient with mCRPC
2. The time course/pattern of symptoms important to quality of life for patients undergoing chemotherapy, abi/enza, or Radium 223
3. If changes in physical activity (quantified by fitbit) predict for changes to ESAS in men undergoing treatment d) Qualitatively assess the supportive care needs of older/frail men with mCRPC

Conditions

Interventions

OTHER

Daily and weekly triggered symptom monitoring

Participants are invited to complete a daily questionnaire, a weekly questionnaire, and to track daily activity with an electronic activity tracker.

Sponsors & Collaborators

  • Prostate Cancer Canada

    collaborator OTHER

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Shabbir Alibhai, MD · University Health Network, Toronto

Eligibility

Min Age
60 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-25
Primary Completion
2021-12-30
Completion
2021-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04193657 on ClinicalTrials.gov